$21.80 0.00 (0.00%) Supernus Pharmaceuticals Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 21.80
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 21.80
Open: 21.25
Bid: 19.25
Ask: 26.60
  1. 5 Stock Picks Ahead Of World Mental Health Day

    TalkMarkets | Oct. 7, 2016 | 14:08PM EST
  2. 2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?

    Investors Business Daily | Aug. 2, 2016 | 15:09PM EST
  3. Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch Names

    Investors Business Daily | Aug. 1, 2016 | 11:20AM EST
  4. Benzinga's Top Upgrades

    Benzinga | Feb. 8, 2016 | 08:55AM EST
  5. 16 Stocks Moving In Friday's After-Hours Session

    Benzinga | Dec. 11, 2015 | 17:03PM EST
  6. Supernus Announces FDA Acceptance of sNDA to Add Migraine to Trokendi XR Label

    Benzinga | Oct. 22, 2015 | 17:39PM EST
  7. Fitbit Keeps Up Pace As Stocks Remain Near Session Highs

    IBD | Jun. 18, 2015 | 13:34PM EST
  8. Benzinga's Top Upgrades

    Benzinga | Jun. 18, 2015 | 08:10AM EST
  9. Jefferies Upgrades Supernus Pharmaceuticals To Buy

    Benzinga | Jun. 18, 2015 | 06:55AM EST
  10. Benzinga's Top Initiations

    Benzinga | Jun. 12, 2015 | 08:19AM EST
  11. Horizon Pharma Up On Bullish Leerink Initiation

    IBD | May. 22, 2015 | 10:39AM EST
  12. Robert Bruce new Buys

    GuruFocus | Feb. 16, 2015 | 10:44AM EST
  13. Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR

    Benzinga | Dec. 10, 2014 | 07:30AM EST
  14. Supernus Reports Issuance of Fifth US Patent Protecting Trokendi XR(R)

    Benzinga | Nov. 24, 2014 | 07:33AM EST
  15. Third Quarter Was Robert Bruce's Busiest in 2014

    GuruFocus | Nov. 21, 2014 | 17:09PM EST
Trading Center